First-in-human robotic percutaneous coronary intervention by the ROSES robotic system: a case report.
Ciro IndolfiAlberto PolimeniSalvatore De RosaGuido DanieliPublished in: European heart journal. Case reports (2023)
In this early clinical experience, the use of the ROSES robotic system seems to be safe and effective. However, this report still represents an early feasibility study, and the use of this technology in more challenging anatomies including the presence of severe tortuosity, severe calcification, or interventions requiring multiple wires and balloons needs to be further studied. A larger, prospective, multicentre pivotal clinical trial designed to test the ROSES robotic angioplasty system in a larger number of patients is currently ongoing.
Keyphrases
- clinical trial
- minimally invasive
- robot assisted
- percutaneous coronary intervention
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- endothelial cells
- early onset
- ejection fraction
- study protocol
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- prognostic factors
- double blind
- st elevation myocardial infarction
- randomized controlled trial
- phase ii
- open label
- drug induced
- patient reported outcomes
- atrial fibrillation
- antiplatelet therapy
- left ventricular
- patient reported
- pluripotent stem cells
- coronary artery bypass
- phase iii